Wall fluidization in two acts: from stiff to soft roughness
Related Experiment Video
Updated: Feb 15, 2026

Stiffness Measurement of Soft Silicone Substrates for Mechanobiology Studies Using a Widefield Fluorescence Microscope
Published on: July 3, 2018
Ladislav Derzsi1, Daniele Filippi, Matteo Lulli
1Dipartimento di Fisica e Astronomia "G. Galilei"- DFA, Università di Padova, via Marzolo, 8 - 35131, Padova PD, Italy. ladislav.derzsi@unipd.it derzsi.ladislav@gmail.com matteo.pierno@unipd.it.
Abstract:
Fluidization of soft glassy materials (SGMs) in microfluidic channels is affected by the wall roughness in the form of microtexturing. When SGMs flow across microgrooves, their constituents are likely trapped within the grooves' gap, and the way they are released locally modifies the fluidization close to the walls. By leveraging a suitable combination of experiments and numerical simulations on concentrated emulsions (a model SGM), we quantitatively report the existence of two physically different scenarios. When the gap is large compared to the droplets in the emulsion, the droplets hit the solid obstacles and easily escape scrambling with their neighbors. Conversely, as the gap spacing is reduced, droplets get trapped inside, creating a "soft roughness" layer, i.e. a complementary series of deformable posts from which overlying droplets are in turn released. In both cases, the induced fluidization scales with the grooves' density, although with a reduced prefactor for narrow gaps, accounting for the softness of the roughness. Both scenarios are also well distinguished via the statistics of the droplets displacement field close to the walls, with large deviations induced by the surface roughness, depending on its stiffness.
Related Concept Videos
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
Directing Proteins to the Rough Endoplasmic Reticulum
Plant Cell Wall
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Acting on Autonomic Ganglia: Blockers

